糖尿病患者在新的治疗方法的可持续性和有效性之间
Francesco Ferrara1, Andrea Zovi2, Roberto Langella3
1Pharmaceutical Department, Hospital Pharmacist Manager, Asl Napoli 3 Sud, Dell'amicizia street 72, Nola, Naples, 80035 Italy.
Journal of diabetes and metabolic disorders
|November 17, 2023
概括
对2型糖尿病药物的宽松处方规则使处方增加了38%,医疗保健支出增加了300多万欧元. 这突显了潜在的处方不适当性,以及改善患者获得治疗的机会.
科学领域:
- 药物经济学 药物经济学
- 公共卫生政策 公共卫生政策
- 内分泌学 在内分泌学.
背景情况:
- 欧洲在COVID-19后的政策旨在增加患者获得2型糖尿病治疗的机会.
- 意大利在2022年初对新的糖尿病药物实施了宽松的处方规则 ("注100").
研究的目的:
- 评估"Note 100"立法对新型2型糖尿病药物的处方模式的影响.
- 在立法实施之前和之后分析处方量,药物消费和相关医疗保健支出的变化.
主要方法:
- 从"健康卡"数据库中分析处方数据.
- 在2021年 (前100注) 和2022年 (后100注) 之间对2型糖尿病药物的处方模式的比较.
主要成果:
- 在2022年,新型2型糖尿病药物的处方和消费量呈指数级增长,增长了38%.
- 在实施"Note 100"之后,这些类药物的医疗保健支出增加了300多万欧元.
结论:
- "Note 100"法规促进了处方以满足未满足的患者需求,但也导致医疗保健支出增加.
- 处方和支出的增加可能表明处方适当性的潜在问题,需要进一步调查.
相关概念视频
Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
210
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
210
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Carbohydrate Metabolism
11.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
Insulin: Dosing Regimen and Adverse Effects
182
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
182


